Fu Jun Li Selected Research

Fu Jun Li Research Topics

3	Chronic Obstructive Pulmonary Disease (COPD) 01/2024 - 01/2017
3	Fibrosis (Cirrhosis) 01/2021 - 01/2017
2	Idiopathic Pulmonary Fibrosis 01/2021 - 01/2017
1	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2024
1	Lung Diseases (Lung Disease) 03/2023
1	Connective Tissue Diseases (Connective Tissue Disease) 03/2023
1	Bronchiolitis Obliterans 01/2023
1	Disease Progression 01/2022
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2022
1	Emphysema 01/2022
1	Burns 01/2021
1	Chemical Burns (Chemical Burn) 01/2021
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2021
1	Lung Injury 01/2019
1	Airway Remodeling 01/2017
1	Granuloma 11/2016
1	Infections 11/2016
1	Inflammation (Inflammations) 01/2015
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 11/2011
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 11/2009

4	CadmiumIBA 01/2024 - 01/2017
4	VimentinIBA 01/2021 - 01/2017
2	SmokeIBA 01/2024 - 01/2021
2	Proteins (Proteins, Gene)FDA Link 01/2017 - 11/2009
1	Chloride Channels (Chloride Channel)IBA 01/2024
1	pirfenidoneIBA 03/2023
1	Irritants (Vesicants)IBA 01/2023
1	Arsenicals (Arsenic Compounds)IBA 01/2023
1	Fibrinogen (Factor I)FDA Link 01/2022
1	Particulate MatterIBA 01/2021
1	serum P-component (CIt)IBA 01/2021
1	SootIBA 01/2021
1	lewisiteIBA 01/2021
1	withaferin AIBA 01/2019
1	Bleomycin (Blenoxane)FDA LinkGeneric 01/2019
1	AutoantigensIBA 01/2017
1	Heme Oxygenase-1IBA 11/2016
1	Cadherins (E-Cadherin)IBA 01/2015
1	immunoglobulin M receptorIBA 11/2011

2	Therapeutics 03/2023 - 01/2021